Post-notification not required for substituted dispensing

Published: 2002-01-18 07:00:00

Updated: 2002-01-18 07:00:00

In the talk meeting for activation of the bio-equivalent test program at Palace hotel on Jan. 16 the MOHW indicated that the government and public hospitals will purchase the drugs proven of its bio-equivalency to the original drugs with priority while deleting the untested drugs from the NHI rei...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK